Search results for "Highlights"
Spotlight on IBD therapy comparisons
Recent research on inflammatory bowel disease (IBD) therapies compared vedolizumab with anti-tumor necrosis factor therapy, risankizumab with ustekinumab for Crohn's disease, and upadacitinib with tofacitinib for ulcerative colitis.
https://gastroenterology.acponline.org/archives/2024/07/26/5.htm
26 Jul 2024
Diagnostic delays in pancreatic cancer relatively common, likely avoidable, study suggests
Thirty-eight percent of patients with pancreatic cancer experienced a diagnostic delay of at least 60 days, with lack of recognition of objective weight loss as the most common cause, a Veterans Affairs study showed.
https://gastroenterology.acponline.org/archives/2024/08/23/1.htm
23 Aug 2024
Adding baclofen may improve GERD symptoms, but long-term use may increase side effects
Add-on therapy with baclofen reduced reflux symptoms among patients with refractory gastroesophageal reflux disease (GERD) but prolonged use led to an increased incidence of side effects and failed to effectively reduce acid reflux occurrence, a review found.
https://gastroenterology.acponline.org/archives/2024/06/28/3.htm
28 Jun 2024
Acute gastroenteritis infection associated with later IBS, functional dyspepsia, review finds
Prevalence of irritable bowel disease and functional dyspepsia were 14.5% and 12.7%, respectively, in patients who had experienced acute gastroenteritis, a risk more than three times higher than that in uninfected patients.
https://gastroenterology.acponline.org/archives/2024/07/26/1.htm
26 Jul 2024
Despite guidelines, some patients opt for second fecal blood test following positive result
Although the proportion of patients who repeat tests after receiving a positive result for colorectal cancer is low, at 7.4%, among those that do repeat tests, less than half go on to receive a colonoscopy, according to a study carried out across four large health systems.
https://gastroenterology.acponline.org/archives/2024/06/28/2.htm
28 Jun 2024
GLP-1s associated with lower risk of hepatic decompensation than other diabetes drugs
Patients taking glucagon-like peptide-1 (GLP-1) receptor agonists for type 2 diabetes had lower risk of hepatocellular carcinoma than those on insulin or sulfonylureas, and hepatic decompensation risk was reduced compared with five comparison diabetes drug classes, a study found.
https://gastroenterology.acponline.org/archives/2024/05/24/2.htm
24 May 2024
Gastro experts offer best practice advice on iron to treat anemia
The American Gastroenterological Association issued a clinical practice update on management of iron-deficiency anemia, including when to use oral versus IV iron and how to handle anemia related to GI conditions.
https://gastroenterology.acponline.org/archives/2024/06/28/1.htm
28 Jun 2024
Colectomy linked with greater risk of AKI, kidney failure in patients with IBD
Among patients with inflammatory bowel disease (IBD), colectomy was linked with more than doubled risk of acute kidney injury (AKI), indicating that these patients may benefit from close monitoring of kidney biomarkers, according to the authors of a Swedish cohort study.
https://gastroenterology.acponline.org/archives/2024/05/24/3.htm
24 May 2024
Higher MAP linked with AKI reversal among hospitalized patients
A 5 mm Hg increase in mean arterial pressure (MAP) was linked with a small but significant increase in the likelihood of reversal of acute kidney injury (AKI), according to a retrospective study of patients hospitalized with decompensated cirrhosis.
https://gastroenterology.acponline.org/archives/2024/04/26/2.htm
26 Apr 2024
GLP-1 receptor agonists could modestly delay gastric emptying during periprocedural fasting, study suggests
A systematic review and meta-analysis found that glucagon-like peptide-1 (GLP-1) receptor agonists were associated with a delay of approximately 36 minutes in gastric emptying on scintigraphy compared to placebo.
https://gastroenterology.acponline.org/archives/2024/04/26/3.htm
26 Apr 2024